1,716 research outputs found
A plant-type enzyme as a putative target for novel antimalarial drugs : properties of the Plasmodium falciparum ferredoxin-NADP+ reductase
Apicomplexan parasites harbor a specific organelle, named apicoplast, which is related to plant non-photosynthetic plastids and displays a plant-like metabolism. The apicoplast has been shown to contain typical vegetal proteins, such as ferredoxin–NADP+ reductase (FNR) and ferredoxin (Fd) (1-2). Both proteins from Plasmodium falciparum (PfFNR and PfFd) have been produced in recombinant form and characterized (3). The PfFNR/PfFd couple was shown to be catalytically active in vitro yielding reducing power to support the activity of LytB (4), the last enzyme of the biosynthetic pathway for isoprenoid precursors, a known site of action of antiplasmodial compounds. On this basis, PfFNR has been proposed as a possible target for new antimalarial drugs (2).
The three-dimensional structure of PfFNR has been determined by X-ray crystallography (3). Compared to other plastidic-type FNRs, PfFNR displays a significantly lower catalytic efficiency and lower selectivity against NADH. These functional features are probably the consequence of the lack of protein positively-charges stabilizing the 2’-phosphate of the bound substrate. NADP(H) binding to PfFNR occurs through an induced-fit mechanism never observed in other FNRs. The conformational changes induced by binding to the enzyme of 2’-P-AMP, a NADP+ analogue, includes the partial unwinding of an α-helix localized in the NADP+-binding domain. Furthermore, the binding of NADP+ triggers the formation of a disulfide-stabilized homodimer resulting in the inactivation of PfFNR. This process, observed in vitro, could represent a physiologic mechanism regulating the enzyme activity.
Structure-based design of PfFNR inhibitors is in progress and has already yielded some active compounds, with inhibitory constants in the range of micromolar or lower.
1. Pandini V. et al. (2002) J. Biol. Chem. 277, 48463-48471
2. Seeber F. et al. (2005) Curr. Farm. Des. 11, 3159-7312
3. Milani et al. (2007) J. Mol. Biol. 367, 501-513
4. Röhrich R.C. et al. (2005) FEBS lett. 579, 6433-643
Structure-function studies of the major insertion of the apicomplexan ferredoxin NADP+ reductase, investigated by mutagenesis and limited proteolysis
Apicomplexan parasites are a large phylum of unicellular and obligate intracellular organisms of great medical and economic importance. They include the human pathogens Plasmodium spp., the causative agents of malaria, and Toxoplasma gondii, an opportunistic human parasite. It was shown that most members of this phylum harbor a plastid-like organelle, called the apicoplast, of vegetal origin. The plant-type ferredoxin/ferredoxin-NADP+ reductase (Fd/FNR) redox system found in this organelle has been proposed as a target for novel drugs (1, 2). Elucidation of the properties and functions of this redox system would be greatly facilitated by a more detailed structural knowledge of the two components. Like many proteins from these protists, apicomplexan FNRs are characterized by the presence of unique peptide insertions of variable length and yet unknown function. The major insertion of T. gondii FNR (TgFNR) (28 aa with respect to maize root FNR) is near the FAD isoalloxazine ring binding motif. Thus, it is expected that it could influence the protein-protein interaction of the redox couple.
The aim of this study was therefore to investigate the structure and the involvement of this region of TgFNR in substrate binding by mutagenesis and limited proteolysis approaches.
All four proteinases tested yielded a limited number of peptides. Most of the cleavage sites were located within the major insertion of TgFNR, indicating that this region is surface exposed and is highly flexible. Furthermore, protection of the insertion by TgFd against proteolytic cleavage indicates a role for this region in ferredoxin binding (3).
Three different deleted forms of the parasite enzyme were produced, in which the insertion was fully removed (Del1), partially removed (Del2) or replaced with the homologous region of plant FNR (Del3). Compared to the wild type enzyme, Del2 and Del3 showed similar values for the kinetic parameters of the TgFd-dependent NADPH-cytochrome c reductase activity, while Km for ferredoxin of Del1 was highly increased. By affinity chromatography on immobilized TgFd, deleted TgFNRs were shown to bind more weakly TgFd than the wild-type enzyme. Del1 showed a remarkable loss of affinity for ferredoxin, probably because it lacks three positively charged residues which are present in Del2 and in Del3 mutants.
The results reported here allow us to conclude that the insertion of TgFNR is solvent exposed and structurally flexible. It is suggested to give rise to a 38-residue intrinsically unstructured subdomain, protruding from the top of the FAD-binding beta-barrel. Such a species-specific subdomain does not have major functions in protein folding and stability. Rather, it participates in TgFd binding, significantly increasing the stability of the protein-protein complex and improving the catalytic efficiency of the enzyme in the electron transfer to TgFd.
1. M. Vollmer et al. (2001) J. Biol. Chem. 276(8): 5483-5490
2. V. Pandini et al. (2002) J Biol Chem. 277(50):48463-48471.
3. V. Pandini et al. (2006) Biochemistry 45: 3563-357
Crystal structure of human renalase, a novel flavoenzyme involved in the pathogenesis of cardiovascular diseases
Renalase is a recently identified flavoprotein (1), highly conserved in vertebrates, with orthologs in other organisms, including lower eukaryotes and bacteria. In humans, renalase is synthetized in kidneys, heart, skeletal muscles, brain and small intestine, being present in blood and urine (2). In mammals, renalase has been shown to regulate blood pressure, sodium and phosphate excretion, and to exert a cardioprotectant action (2). Despite its medical relevance, the mechanism of renalase action is not known at the molecular level (3); based on its moderate sequence similarity to monoamine oxidases (MAOs), it has been proposed to be a catecholamine degrading enzyme. To gain insight into its catalytic activity, we produced human renalase in Escherichia coli and showed that it contains non-covalently bound FAD (4), slightly stabilizes the neutral flavin semiquinone, and reacts slowly with sodium dithionite to yield a flavin adduct, with a Kd of ca. 2 mM. We found that renalase is devoid of any measurable catecholamine oxidase or dehydrogenase activities. Further, we solved the crystal structure of human renalase at 2.5 Å resolution. The protein adopts the p-hydroxybenzoate hydroxylase fold, and is structurally related to MAO-like enzymes. However, renalase is composed of two domains, thus lacking the third domain conserved in the other members of the family. A cavity (228 Å3), facing the re-face of the isoalloxazine, likely representing the active site, opens to the molecular surface. Compared to mono- or poly-amine oxidases, the renalase putative active-site lacks both a conserved Lys, that would interact via a water molecule with the N5 atom of the flavin ring, and the ‘aromatic cage’ expected to bind the substrate amino-group. Although these data do not allow to assign a catalytic activity to renalase yet, our studies represent a reference framework to test hypotheses on the enzyme molecular mechanism of action.
References
1)Xu, J., Li, G., Wang, P., Velazquez, H., Yao, X., Li, Y., Wu, Y., Peixoto, A., Crowley, S., Desir, G.V. (2005) J. Clin. Invest. 115, 1275-1280.
2)Desir, G. V. (2011) Curr. Opin. Nephrol. Hypertens. 20, 31-36.
3)Eikelis, N., Hennebry, S.C., Lambert, G.W., Schlaich, M.P. (2011) Kidney Int. 79, 1380.
4)Pandini, V., Ciriello, F., Tedeschi, G., Rossoni, G., Zanetti, G., Aliverti, A. (2010) Protein Expr. Purif. 72, 244-253
Strain rate dependence of the anisotropic fracture toughness of rubber-modified polypropylene films
A rubber modified cast polypropylene film has been tested by the essential work of fracture method to assess the effect of material orientation on the fracture toughness. The tests have been performed under different quasi-static rates, in order to analyze the strain rate effects on the material toughness: impact rates were also considered, but results are still at a preliminary stage. Results indicate a marked anisotropy with higher essential work of fracture values for cracks propagating transversally to the extrusion direction. Fracture toughness in both direction is substantially independent of testing speed up to 500 mm/min and markedly decreases under impact conditions. Furthermore, the specific essential work of fracture was partitioned into two terms, one representing the specific work for yielding up to the onset of fracture, and another term related to the specific work for subsequent necking and tearing. Scanning electron microscopy observations have been conducted to reveal fracture surfaces morphology
Time, temperature, and strain effects on viscoelastic Poisson's ratio of epoxy resins
Poisson's ratio of polymeric materials, although generally assumed as a constant, is known to display a viscoelastic dependence on time, temperature, and strain. This article investigates the phenomenology of this dependence on two crosslinked epoxy systems with different glass transition temperatures. Poisson's ratio measurements are performed by contact extensometers simultaneously measuring the axial and transverse deformations under two different tensile testing conditions: (i) constant deformation rate, in which the effects of strain, strain rate, and temperature are highlighted; (ii) stress relaxation (or constant deformation), where the dependence of Poisson's ratio on time is studied at various strain levels. The viscoelastic Poisson's ratio increases as strain, temperature, and time increases, with trends markedly depending on the materials glass transition
Functional characterization of Plasmodium falciparum ferredoxin-NADP+ reductase
Apicomplexa are protozoan parasites responsible for infective diseases of major worldwide impact, like malaria or toxoplasmosis. We have identified and characterized a redox system of Toxoplasma gondii (1), comprising ferredoxin-NADP+ reductase and ferredoxin, which is of vegetal origin and has not a homolog in the human host, thus being possibly a novel drug target (2). This system is localized in the apicoplast, an organelle shown to be essential for parasite survival both in P. falciparum and T. gondii. Recently, we have demonstrated the ability of the redox system FNR/Fd of P. falciparum to reconstitute in vitro the electron transfer pathway to the enzyme LytB which catalyzes the last step of the mevalonate-independent isoprenoid biosynthesis in the apicoplast (3). Here, we report a thorough characterization of the ferredoxin-NADP+ reductase of P. falciparum (PfFNR). We have cloned and overproduced in Escherichia coli the PfFNR in soluble and active form. The recombinant PfFNR, purified to homogeneity, has been studied with respect to the spectral properties and the interaction with its protein partner P. falciparum ferredoxin. Steady-state and rapid kinetics studies show several differences between the P. falciparum redox system and those of both plants and T.gondii. Redox titration experiments indicate that redox potential of the FAD prosthetic group of PfFNR is by far more positive than that of photosynthetic FNRs. Inhibition studies with organic and transition metal salts are in progress as well as the screening of conditions to obtain crystals for X-ray structure analysis.
1 Pandini V., Caprini G., Thomsen N., Aliverti A., Seeber F., Zanetti G. (2002) J. Biol. Chem. 277, 48463-48471.
2 Seeber F., Aliverti A., Zanetti G. (2005) Curr. Pharm. Des. 11, 3159-3172.
3 Rohrich RC, Englert N, Troschke K, Reichenberg A, Hintz M, Seeber F, Balconi E, Aliverti A, Zanetti G, Kohler U, Pfeiffer M, Beck E, Jomaa H, Wiesner J. (2005) FEBS Lett. 579,6433-8
New insights on the molecular mechanism of action of human renalase
Renalase is a new human flavoprotein possibly involved in blood pressure and cardiac function regulation1. Despite the potential implications for human health, the biochemical properties of renalase have not been investigated so far, so that the molecular mechanism underlying its action is far from been understood. The low sequence identity with MAOs led to the hypothesis that renalase could represents a new class of monoamine oxidases, acting by degrading plasma catecholamines2,3. In order to elucidate the mechanism of action of human renalase at a molecular level, three recombinant forms of human renalase were produced in E. coli yielding amounts of protein suitable for its biochemical characterization4. Spectroscopic analyses revealed for the first time that renalase is a flavoprotein, with FAD as noncovalently-bound cofactor. At variance with MAOs, recombinant renalase was found to be devoid of any oxidase activity toward biogenic amines. Nevertheless, its unusual reactivity towards various compounds sheds a new light on the nature of the reaction catalyzed by this enzyme.
1. Xu J. et al. (2005) J. Clin. Invest. 115, 1275-1280
2. Li G. et al. (2008) Circulation 117, 1277-1282
3. Wang J. et al. (2008) Mol. Biol. Rep. 35, 613-620
4. Pandini V. et al. (2010) Protein Expr. Purif. 72, 244-5
Ferredoxin–NADP+ reductases of Apicomplexa: unique properties of protozoan plant–type enzymes
Plant-type ferredoxin-NADP+ reductases (FNRs) are a family of flavin-dependent dehydrogenases/electron transferases ubiquitous in plant plastids, cyanobacteria and some eubacteria (1). Recently, FNRs have been identified in the apicoplast of apicomplexan parasites, which includes the causative agents of malaria and toxoplasmosis. FNRs from Toxoplasma gondii (TgFNR) and Plasmodium falciparum (PfFNR) have been cloned and characterized (2, 3). Whereas TgFNR failed to yield crystals suitable for X-ray analysis, the crystal structure of PfFNR has been determined (3). Compared to FNRs from other sources, PfFNR displays a significantly lower catalytic efficiency and poorer NADH/NADPH selectivity (3). These features of PfFNR have been interpreted on the basis of the peculiar structure of its NADP(H)-binding site. Furthermore, PfFNR undergoes an unprecedented NADP-triggered, redox-dependent homodimerization process leading to enzyme inactivation, which could represent a physiologic mechanism of enzyme regulation. PfFNR has been shown to be involved in the biosynthesis of isoprenoid precursors (4), which is the site of action of known antiplasmodial compounds. On this basis, apicomplexan FNRs have been proposed as a possible new target for novel antiparasitic drugs (2).
References
1. Aliverti, A., Pandini, V., Pennati, A., de Rosa, M., and Zanetti, G., Arch. Biochem. Biophys., 474, 283-291 (2008).
2. Seeber, F., Aliverti, A., and Zanetti, G., Curr. Farm. Des., 11, 3159-7312 (2005).
3. Milani, M., Balconi, E., Aliverti, A., Mastrangelo, E., Seeber, F., Bolognesi, M., and Zanetti, G., J. Mol. Biol., 367, 501-513 (2007).
4. Röhrich, R.C., et al., FEBS Lett., 579, 6433–6438 (2005)
Plasmodium falciparum ferredoxin-NADP+ reductase : a plant-type enzyme as a promising new target for novel antimalarial drugs
INTRODUCTION: Plant-type ferredoxin-NADP+ reductases (FNRs) are a widespread group of flavin-dependent enzymes that catalyze the exchange of reducing equivalents between NADP(H) and ferredoxin (Fd) (1). FNRs have been found in plant plastids, cyanobacteria and some eubacteria (1), where they form electron transport chains involved in biosynthetic processes as diverse as photosynthesis, nitrogen assimilation, and response against reactive oxygen species. FNRs have been recently identified in the apicoplast of apicomplexan parasites (2, 3), which includes the causative agents of malaria and toxoplasmosis. Plasmodium falciparum FNR (PfFNR) and Fd (PfFd) have been cloned and functionally characterized (4-6). The PfFNR/PfFd couple has been shown to support in vitro the activity of LytB (6), the last enzyme of the biosynthetic pathway for isoprenoid precursors, which is the site of action of known antiplasmodial compounds. On this basis, PfFNR has been proposed as a possible new target for antimalarial drugs (3).
RESULTS: The structure of PfFNR has been determined by X-ray crystallography. Compared to other plastidic-type FNRs, PfFNR displays a significantly lower catalytic efficiency and lower selectivity against NADH. These functional features are probably the consequence of the lack of protein positively-charged groups stabilizing the 2’-phosphate of bound substrate. PfFNR interacts with the adenine moiety of the bound NADP(H) through a His residues not conserved in other FNRs. The role of this residue in catalysis has been investigated by site-directed mutagenesis. NADP(H)-binding to PfFNR occurs through an induced-fit mechanism unprecedented in other enzyme of this protein family. The conformational changes induced by binding to the enzyme of 2’-P-AMP, a NADP analogue, include the partial disruption of an α-helix localized in the NADP-binding domain. Furthermore, PfFNR was shown to undergo NADP+-triggered homodimerization in vitro, resulting in the formation of an intermolecular disulfide bridge and leading to enzyme inactivation. This process, which can be fully reversed by cleaving the disulfide by reductants like DTT or lipoate, could represent a physiologic mechanism regulating the enzyme activity. Structure-based design of PfFNR inhibitors is in progress and has already yielded some active compounds.
1. Ceccarelli E.A. et al. (2004) Biochim. Biophys. Acta 1698, 155-165
2. Pandini V. et al. (2002) J. Biol. Chem. 277, 48463-48471
3. Seeber F. et al. (2005) Curr. Farm. Des. 11, 3159-7312
4. Milani M. et al. (2007) J. Mol. Biol. 367, 501-513
5. Kimata–Ariga Y. et al. (2007) J. Biochem. 142, 715-720
6. Röhrich R.C. et al. (2005) FEBS Lett. 579, 6433–643
- …
